News
Market and company headlines
CLAYMONT, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Archimedes Tech SPAC Partners II Co. (Nasdaq: ATII) (“Archimedes II” or “ATII”), a publicly traded special purpose acquisition company, today announced that at the Extraordinary General Meeting (the “Meeting”) held today, October 16, 2026, ATII’s shareholders voted to approve the previously announced business combination (the “Business Combination”) between ATII and Forge Nano, Inc. (“Forge Nano”), as well as all other proposals related to the Bu

rchimedes Tech SPAC Partners II Co. (NASDAQ:ATII) ("Archimedes II" or "ATII"), a publicly traded special purpose acquisition company, today announced that at the Extraordinary General Meeting (the

Collaboration intended to develop large-scale, GMP-compliant ALD manufacturing equipment supporting Nanexa’s broad portfolio of proprietary and partnered PharmaShell® programs. DENVER and UPPSALA, Sweden, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition (“ALD”) technology for artificial intelligence (“AI”)-era chip manufacturing and defense battery applications, which has signed an

Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale
